Profile
BDSX DHR-PB TMO DHR A IDXX
Company Name Biodesix, Inc. Danaher Corporation Thermo Fisher Scientific Inc. Danaher Corporation Agilent Technologies, Inc. IDEXX Laboratories, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research Medical - Diagnostics & Research
Market Cap $180.63M $916.76B $227.24B $196.87B $45.20B $44.88B
Employees 0.22K 79.00K 122.00K 61.00K 17.70K 11.00K
CEO Mr. Scott Hutton Mr. Rainer M. Blair Mr. Marc N. Casper Mr. Rainer M. Blair Mr. Henrik Ancher-Jensen Mr. Jonathan J. Mazelsky
Ratings
Trading
BDSX DHR-PB TMO DHR A IDXX
Last Close $1.575 $1261.26 $595.3 $265.8 $154.23 $543.45
High 52 $2.13 $1261.26 $599.43 $265.8 $154.31 $576.87
Low 52 $1.04 $1261.26 $431.41 $185.1 $101.17 $391.37
Price vs. 52 Week High -26.06 % 0 % -0.69 % 0 % -0.05 % -5.79 %
Price vs. 52 Week Low 51.44 % 0 % 37.99 % 43.6 % 52.45 % 38.86 %
Total Return
BDSX DHR-PB TMO DHR A IDXX
1 Month Return 26 % 0 % 9.93 % 12.46 % 16.45 % 13.74 %
3 Month Return 6.42 % 0 % 8.66 % 6.32 % 14.38 % -2.18 %
6 Month Return 10.14 % 0 % 27.63 % 27.92 % 36.31 % 17.2 %
9 Month Return 4.3 % 0 % 11.82 % 5.72 % 29.33 % 12.35 %
YTD Return -14.4 % 0 % 12.15 % 14.9 % 10.93 % -2.09 %
1 Year Return 38.16 % 0 % 13.71 % 17.39 % 19.43 % 10.44 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
BDSX DHR-PB TMO DHR A IDXX
Dividend Yield Percentage (TTM) - 0.38 % 0.24 % 0.38 % 0.6 % -
Dividend Paid and Capex Coverage Ration (TTM) -1.9 % 3.16 % 4.68 % 2.65 % 3.39 % 7.41 %
Dividend Per Share (TTM) - 1.02 % 1.44 % 1.02 % 0.92 % -
Payout Ratio (TTM) - 17.87 % 8.97 % 27.74 % 21.6 % -
Growth
BDSX DHR-PB TMO DHR A IDXX
Asset Growth 6.66 % 0.16 % 1.62 % 0.16 % 2.35 % 18.68 %
Gross Profit Growth 38.05 % -25.94 % -21.93 % -25.94 % -6.9 % 9.26 %
Revenue Growth 28.46 % -24.09 % -4.58 % -24.09 % -0.22 % 8.72 %
Revenue 3 Year -65.15 % 2.8 % 36.47 % 2.8 % 34.51 % 38.96 %
Revenue 5 Year -23.55 % 14.24 % 83.24 % 14.24 % 51.82 % 72.97 %
Revenue 10 Year -23.55 % 18.09 % 205.6 % 18.09 % 16.86 % 240.27 %
EBIT Growth 18.23 % -40.12 % -12.81 % -40.12 % -16.56 % 22.07 %
Net Income Growth 35.13 % -33.92 % -13.74 % -33.92 % -1.12 % 24.44 %
Net Income 3 Yeari Growth Per Share 53.75 % 25.29 % -3.52 % 25.29 % 81.26 % 49.23 %
Net Income 5 Yeari Growth Per Share 36.58 % 70.95 % 112.51 % 70.95 % 328.44 % 134.38 %
Net Income 10 Yeari Growth Per Share 36.58 % 67.05 % 339.48 % 67.05 % 98.65 % 475.93 %
Operating Income Growth 18.23 % -40.12 % -12.81 % -40.12 % -16.56 % 22.07 %
Operating Cash Flow Growth (CFG) 49.15 % -15.91 % -8.17 % -15.91 % 35.06 % 66.95 %
Operating 3 Year CFG 65.38 % 10.65 % 4.04 % 10.65 % 102.22 % 43.71 %
Operating 5 Year CFG 58.83 % 69.44 % 92.7 % 69.44 % 77.99 % 136.94 %
Operating 10 Year CFG 58.83 % 88.83 % 290.23 % 88.83 % 78.41 % 371.66 %
EPS Growth 66.49 % -34.29 % -12.41 % -34.29 % 0.72 % 25.25 %
EPS Diluted Growth 66.49 % -33.82 % -12.41 % -33.82 % 0.24 % 25.28 %
Book Value Per Share -88.6 % 5.14 % 7.9 % 5.14 % 12.39 % 145.51 %
Share Holder 3 Year Equity Growth Per Share -96.4 % 28.97 % 38.91 % 28.97 % 26.07 % 141.3 %
Share Holder 5 Year Equity Growth Per Share 100.74 % 80.33 % 76.4 % 80.33 % 39.74 % 16418.79 %
Share Holder 10 Year Equity Growth Per Share 100.74 % 125.79 % 158.74 % 125.79 % 28.25 % 266.68 %
Dividend Per Share Growth - 50.21 % 16.73 % 50.21 % 7.8 % -
Dividend 3 Year Growth Per Share - 94.58 % 59.21 % 94.58 % 25.46 % -
Dividend 5 Year Growth Per Share - - - - - -
Dividend 10 Year Growth Per Share - 2163.67 % 125.8 % 2163.67 % 97.03 % -
Debt Growth 90.55 % -0.72 % 1.24 % -0.72 % -1.23 % -29.7 %
Free Cash Flow Growth 5.31 % -21.53 % 0.23 % -21.53 % 44.37 % 96.09 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Oct 2023 31 Dec 2023
Profitability
BDSX DHR-PB TMO DHR A IDXX
Gross Profit Margin TTM 76.27 % 58.45 % 41.2 % 58.4 % 50.63 % 60.14 %
Return on Assets TTM -53.96 % 5.33 % 6.21 % 5.28 % 11.29 % 25.84 %
Return on Equity TTM 2010.81 % 8.42 % 13.31 % 8.34 % 21.15 % 63.66 %
Return on Capital Employed TTM -64.14 % 7.39 % 8.44 % 5.54 % 14.19 % 46.55 %
Net Income Per EBT TTM 100 % 83.98 % 92.49 % 97.45 % 92.79 % 79.58 %
EBT Per Ebit TTM 131.09 % 94.74 % 92.99 % 107.86 % 100.6 % 97.61 %
EBIT Per Revenue TTM -65.45 % 21.3 % 16.51 % 18.6 % 19.66 % 29.95 %
Cash Flow To Debt Ratio TTM -82.84 % 36.11 % 25.07 % 36.11 % 75.39 % 86.18 %
Receivables Turnover TTM 5.54 7.76 4.54 6.66 5.2 6.44
Payables Turnover TTM 4.05 6.49 9.78 5.58 6.81 12.64
Inventory Turnover TTM 9.3 4.12 4.87 3.54 3.22 3.8
Fixed Asset Turnover TTM 182.03 % 463.28 % 455.73 % 397.72 % 458.48 % 449.53 %
Asset Turnover TTM 62.9 % 31.45 % 43.76 % 27 % 61.52 % 111.07 %
Operating Cash Flow Per Share TTM -0.31 9.27 23.37 9.39 6.69 11.09
Free Cash Flow Per Share TTM -0.47 7.39 19.79 7.5 5.63 9.59
Cash Per Share TTM 11.93 % 937.04 % 1899.74 % 949.37 % 596.59 % 478.28 %
Operating Cash Flow Sales Ratio TTM -54.11 % 26.52 % 21.01 % 30.89 % 29.12 % 24.73 %
Free Cash Flow Operating Cash Flow Ratio TTM 152.66 % 79.76 % 84.68 % 79.89 % 84.09 % 86.5 %
Cash Flow Coverage Ratios TTM -82.84 % 36.11 % 25.07 % 36.11 % 75.39 % 86.18 %
Price To Free Cash Flows Ratio TTM -3.99 35.49 30.06 35.43 27.41 56.33
Price To Operating Cash Flows Ratio TTM -5.16 28.67 25.47 28.3 23.04 49.02
Price Cash Flow Ratio TTM -5.16 28.67 25.47 28.3 23.04 49.02
Income Statement (TTM)
BDSX DHR-PB TMO DHR A IDXX
Revenue $0.05B $23.89B $42.86B $23.89B $6.83B $3.66B
Gross Profit $0.03B $14.03B $15.22B $14.03B $3.47B $2.19B
Gross Profit Ratio 67.66% 58.74% 35.52% 58.74% 50.71% 59.82%
EBITDA $-0.04B $7.76B $10.72B $7.76B $1.71B $1.1B
Net Income $-0.05B $4.76B $6B $4.76B $1.24B $0.85B
EPS Diluted -0.64 6.38 15.45 6.38 4.19 10.06
Balance Sheet (MRQ)
BDSX DHR-PB TMO DHR A IDXX
Long Term Debt $0.04B $17.66B $31.31B $17.66B $2.74B $0.62B
Total Liabilities $0.09B $31B $51.88B $31B $4.92B $1.78B
Total Equity $0B $53.49B $46.84B $53.49B $5.85B $1.48B
Total Investments $0B $0.01B $-1.92B $0.01B $0.16B $0.06B
Total Debt $0.06B $19.54B $34.92B $19.54B $2.74B $0.95B
Total Assets $0.1B $84.49B $98.73B $84.49B $10.76B $3.26B
Cash Flow Statement (TTM)
BDSX DHR-PB TMO DHR A IDXX
Net Income $-0.05B $4.22B $6B $4.22B $1.24B $0.85B
Inventory $0B $0.19B $0.6B $0.19B $-0.03B $-0.03B
Dividends Paid $0B $-1.25B $-0.52B $-1.25B $-0.27B $0B
Operating Cash Flow $-0.02B $7.16B $8.41B $7.16B $1.77B $0.91B
Capital Expenditure $-0.02B $-1.38B $-1.48B $-1.38B $-0.3B $-0.13B
Related Stocks
Ticker Name Price
A Agilent Technologies, Inc. 154.23
ACRS Aclaris Therapeutics, Inc. 1.19
AKU Akumin Inc. 0.2887
APDN Applied DNA Sciences, Inc. 2.51
AWH Aspira Women's Health Inc. 2.66
BIAF bioAffinity Technologies, Inc. 2.26
BIAFW bioAffinity Technologies, Inc. 0.32
BIOC Biocept, Inc. 0.4349
BNGO Bionano Genomics, Inc. 1.14
BNR Burning Rock Biotech Limited 8.3
CDNA CareDx, Inc 15.5
CEMI Chembio Diagnostics, Inc. 0.455
CHEK Check-Cap Ltd. 2.185
CNTG Centogene N.V. 0.37
CO Global Cord Blood Corporation 2.9876
CRL Charles River Laboratories International, Inc. 221.61
CSTL Castle Biosciences, Inc. 24.24
DGX Quest Diagnostics Incorporated 144.34
DHR Danaher Corporation 265.8
DHR-PA Danaher Corporation 1841.01
ETFs With Exposure to BDSX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 262.3
VXF Vanguard Extended Market Index Fund 0 173.42
IWC iShares Micro-Cap ETF 0.01045 119.09
VTSAX Vanguard Total Stock Market Index Fund 0 127.64
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 131.58
VITSX Vanguard Total Stock Market Index Fund 0 127.66
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000114936 89.84
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 131.58
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 324.71
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 239.45
Unlock